Sonic Healthcare Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sonic Healthcare Limited with three other
pharmaceutical manufacturers in Australasia:
Mayne Pharma Group Limited
sales of 572.60 million Australian Dollars [US$459.91 million]
of which 73%
was Generic Products),
Integral Diagnostics Ltd
(180.10 million Australian Dollars [US$144.66 million]
of which 100%
was Health Service), and
(692.79 million Australian Dollars [US$556.46 million]
Sonic Healthcare Limited reported sales of A$5.12 billion (US$4.11 billion)
June of 2017.
increase of 2.1%
versus 2016, when the company's sales were A$5.02 billion.
Sales at Sonic Healthcare Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 56%).
Sales of Laboratory saw an increase
that was more than double the company's growth rate: sales were up
6.1% in 2017, from
A$4.18 billion to A$4.44 billion.
Sonic Healthcare Limited also saw significant increases in sales in
Imaging and Radiology (up 5.0% to A$441.75 million)
Not all segments of Sonic Healthcare Limited experienced an increase in sales in 2017:
sales of Other fell 7.2% to A$423.87 million.